The description of how the system works to attack cancer cells sounds absolutely incredible. The scientists used the nanoparticles to send a message to the CRISPR enzyme Cas9 to target cancer ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Researchers using CRISPR-Cas9 gene editing tools have discovered that while this technology can enhance T cell cancer therapies ... technologies' safety profiles before widespread clinical application ...

This study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in lymphoma development and therapy.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

CTX001 is an ‘ex vivo’ application of gene-editing, in which the technology is used to modify a patient’s own cells outside the body. It uses CRISPR/Cas9 to make a patient’s haematopoietic ...